We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
-17.09%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$141M
Cap. Flow
+$250M
Cap. Flow %
67.96%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$250M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$42.1B
$198M 53.79%
+9,024,031
New +$250M
FULC icon
2
Fulcrum Therapeutics
FULC
$288M
$71.2M 19.37%
5,962,202
– –
VYGR icon
3
Voyager Therapeutics
VYGR
$189M
$58.5M 15.91%
6,391,176
– –
NTGN
4
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$25.7M 7%
9,741,636
– –
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$14.5M 3.94%
3,048,780
– –

Similar funds

TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

TRV GP III's Q1 2020 Portfolio in Review

As of Q1 2020, TRV GP III held 5 positions worth $368M, up 62% from $226M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP III deployed $250M of net new capital in Q1 2020, opening 1 new position. Its largest new stake was Revolution Medicines: 9,024,031 shares worth $198M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's largest Q1 2020 buy was Revolution Medicines: 9,024,031 shares worth $198M.
  • TRV GP III's ten largest holdings make up 100% of its $368M portfolio in Q1 2020.
  • TRV GP III opened 1 new position and closed 0 in Q1 2020.
  • TRV GP III's portfolio value rose 62% quarter-over-quarter to $368M.

Based on TRV GP III's 13F filing for Q1 2020, filed 11 May 2020.